Kimberly Y Lin, MD
Associate Professor of Pediatrics (Cardiology) at the Children's Hospital of Philadelphia
Attending Physician, Department of Pediatrics, Division of Cardiology, The Children's Hospital of Philadelphia
Co-Director, Penn-CHOP Joint Familial Cardiomyopathy Program
Cardiac Director, Penn-CHOP Friedreich Ataxia Center of Excellence
Medical Director, Pediatric Cardiomyopathy Program, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
3401 Civic Center Blvd, 8NW86
Philadelphia, PA 19104
3401 Civic Center Blvd, 8NW86
Philadelphia, PA 19104
Office: 267-426-2882
Fax: 215-590-1340
Fax: 215-590-1340
Education:
B.A.
University of Michigan, College of Literature, Science and Arts, 1998.
M.D.
University of Michigan, Medical School, 2002.
Permanent linkB.A.
University of Michigan, College of Literature, Science and Arts, 1998.
M.D.
University of Michigan, Medical School, 2002.
Description of Clinical Expertise
CardiomyopathyHeart transplantation
Heart failure
Pediatrics
Description of Research Expertise
CardiomyopathyHeart transplantation
Heart failure
Biomarkers
Pediatrics
Selected Publications
Masood IR, Wang L, Stanley HM, Edwards JJ, Ahmed H, Lin KY, Wittlieb-Weber CA, O'Connor MJ, Rossano JW, O'Malley S, Paridon SM, Tam VW, Edelson JB: Impact of Neighborhood Factors on Exercise Capacity in Children With Hypertrophic Cardiomyopathy. Circulation: Heart Failure Jun 2025 Notes: Epub ahead of print.Meisner JK, Renberg A, Smith ED, Tsan Y-C, Elder B, Bullard A, Merritt OL, Zheng SL, Lakdawala NK, Owens AT, Ryan TD, Miller EM, Rossano JW, Lin KY, Claggett BL, Ashley EA, Michels M, Lampert R, Stendahl JC, Abrams D, Semsarian C, Parikh VN, Wheeler MT, Ingles J, Olivotto I, Day SM, Saberi S, Russell MW, Previs M, Ho CY, Ware JS, Helms AS: Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy. Circulation 151(11): 783-798, Mar 2025.
Lynch DR, Subramony S, Lin KY, Mathews K, Perlman S, Yoon G, Rummey C: Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia. Pediatric Cardiology 46(2): 379-382, Feb 2025.
Tamaroff J, Nguyen S, Wilson NE, Stefanovski D, Xiao R, Scattergood T, Capiola C, Schur GM, Dunn J, Dedio A, Wade K, Shah H, Sharma R, Mootha VK, Kelly A, Lin KY, Lynch DR, Reddy R, Rickels MR, McCormack SE: Insulin sensitivity and insulin secretion in adults with Friedreich's Ataxia: the role of skeletal muscle. J Clin Endocrinol Metab 110(2): 317-333, Jan 2025.
Maurizi N, Antiochos P, Owens A, Lakdwala N, Saberi S, Russell MW, Fumagalli C, Skalidis I, Lin KY, Nathan AS, De Feria Alsina A, Reza N, Stendahl JC, Abrams D, Semsarian C, Clagget B, Lampert R, Wheeler M, Parikh VN, Ashley E, Michels M, Rossano J, Ryan TD, Ingles J, Ware J, Ho CY, Helms AS, Day SM, Olivotto I: Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry. Circulation 150(17): 1377-1390, Oct 2024.
Matesanz SE, Edelson JB, Iacobellis KA, Mejia E, Brandsema JF, Wittlieb-Weber CA, Okunowo O, Griffis H, Lin KY: Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States. Neurology Clinical Practice 14(4), Aug 2024.
Ireland CG, Burstein DS, Day SM, Axelsson Raja A, Russell MW, Zahka KG, Pereira A, Canter CE, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Soslow JH, Becker JR, Giverts I, Orav EJ, Claggett B, Lin KY#, Ho CY#: Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial. Circ Heart Failure Aug 2024 Notes: #Co-senior authors (equal contribution). Epub ahead of print.
Perry CE, Halawani SM, Mukherjee S, Ngaba LV, Lieu M, Lee WD, Davis JG, Adzika GK, Bebenek AN, Bazianos DD, Chen B, Mercado-Ayon E, Flatley LP, Suryawanshi AP, Ho I, Rabinowitz JD, Serai SD, Biko DM, Tamaroff J, DeDio A, Wade K, Lin KY, Livingston DJ, McCormack SE, Lynch DR, Baur JA: NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia JCI Insight 9(16), Jul 2024.
Mejia EJ, Xiao R, Walter JK, Feudtner C, Lin KY, DeWitt AG, Prasad Kerlin M: Programmatic Palliative Care Consultations in Pediatric Heart Transplant Evaluations. Pediatric Cardiology 45(5): 1064-1071, Jun 2024.
Lynch DR, Sharma S, Hearle P, Greeley N, Gunther K, Keita M, Strawser C, Hauser L, Park C, Schadt K, Lin KY: Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxia. J Neurol Sci 461, Jun 2024.